Physician

Adolfo Ramirez-Zamora, M.D.

According to 2025 Medicare claims, Adolfo Ramirez-Zamora, M.D. (NPI: 1922261270) practices neurology in the Gainesville, FL market, with the plurality of this provider's patient population coming from Alachua, FL. This provider's primary affiliated billing organization is FLORIDA CLINICAL PRACTICE ASSOCIATION INC (NPI: 1063463768; TIN: 59-1680273) and primary practice location at 32608-3928. Ramirez-Zamora is affiliated with the UF HEALTH ACO GAINESVILLE, LLC (ACO ID: A5468), participating under the MSSP model.

Ramirez-Zamora's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 278 traditional Medicare patients, billed 24,845 HCPCS/CPT codes, and received $188,378 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 950 prescription claims across 184 beneficiaries totaling $166,396 in drug costs, led by Rytary (Carbidopa/Levodopa). 2016 DME data shows 88 claims. Open Payments data shows 91 records totaling $75,439. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $117,892 to $188,378. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $628,842 to $166,396. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	247	12,968	$117,892
2016	271	12,877	$106,029
2017	291	608	$67,967
2018	312	1,080	$71,261
2019	344	929	$69,765
2020	328	19,825	$179,718
2021	328	44,212	$296,446
2022	267	44,485	$284,249
2023	334	36,409	$282,335
2024	278	24,845	$188,378

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	220	3,108	$628,842
2016	226	3,164	$746,338
2017	233	1,342	$261,324
2018	139	897	$149,778
2019	183	1,104	$479,593
2020	177	1,149	$388,099
2021	119	431	$73,054
2022	132	571	$97,600
2023	155	767	$97,410
2024	184	950	$166,396

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	88	$151,681
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	96	120	$89
95983	Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional	61	84	$36
95984	Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional	59	294	$33
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	95	120	$13
J0585	Injection, onabotulinumtoxina, 1 unit	45	22,110	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rytary	Carbidopa/Levodopa	24	1,054	$31,434
Carbidopa-Levodopa	Carbidopa/Levodopa	171	11,304	$5,617
Carbidopa-Levodopa Er	Carbidopa/Levodopa	79	4,973	$5,533
Ropinirole Er	Ropinirole Hcl	17	1,110	$3,549
Rivastigmine	Rivastigmine	13	450	$3,154

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	87	$52,499	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$22,940	Medtronic, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adolfo Ramirez-Zamora, M.D.?

Tedicare shows public-source Medicare data for Adolfo Ramirez-Zamora, M.D. (NPI 1922261270), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adolfo Ramirez-Zamora, M.D. have ACO affiliation data?

Adolfo Ramirez-Zamora, M.D. is shown with ACO affiliation data for UF HEALTH ACO GAINESVILLE, LLC (MSSP, ACO ID A5468).

What billing organization is linked to Adolfo Ramirez-Zamora, M.D.?

Adolfo Ramirez-Zamora, M.D. is linked to FLORIDA CLINICAL PRACTICE ASSOCIATION INC (billing NPI 1063463768) in the available physician profile data.

Does Adolfo Ramirez-Zamora, M.D. have Open Payments data?

Adolfo Ramirez-Zamora, M.D. has 91 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.